Symbol:
Arhgef3
Name:
Rho guanine nucleotide exchange factor 3
RGD ID:
1310672
Description:
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in positive regulation of Rho protein signal transduction. Predicted to be located in cytoplasm. Orthologous to human ARHGEF3 (Rho guanine nucleotide exchange factor 3); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC290541; Rho guanine nucleotide exchange factor (GEF) 3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 2,308,311 - 2,588,634 (+) NCBI GRCr8 mRatBN7.2 16 2,301,573 - 2,581,951 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 2,300,138 - 2,581,945 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 16 2,519,162 - 2,588,620 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 3,664,854 - 3,734,303 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 2,523,968 - 2,593,442 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 2,743,714 - 3,026,768 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 2,743,823 - 3,026,760 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 16 2,595,636 - 2,665,051 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 16 2,473,664 - 2,663,130 (+) NCBI Celera 16 2,477,340 - 2,546,773 (+) NCBI Celera Cytogenetic Map 16 p16 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Arhgef3 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 Arhgef3 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ARHGEF3 mRNA CTD PMID:32145629 Arhgef3 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ARHGEF3 mRNA CTD PMID:35192832 Arhgef3 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Arhgef3 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Arhgef3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Arhgef3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGEF3 mRNA CTD PMID:19933214 Arhgef3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGEF3 mRNA CTD PMID:33387578 and PMID:34747641 Arhgef3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Arhgef3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGEF3 mRNA CTD PMID:21570461 Arhgef3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGEF3 mRNA CTD PMID:21215274 Arhgef3 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of ARHGEF3 mRNA CTD PMID:21346803 Arhgef3 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ARHGEF3 mRNA CTD PMID:21346803 Arhgef3 Rat 2-palmitoylglycerol increases expression ISO ARHGEF3 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of ARHGEF3 mRNA CTD PMID:37199045 Arhgef3 Rat 4,4'-sulfonyldiphenol increases expression ISO Arhgef3 (Mus musculus) 6480464 bisphenol S results in increased expression of ARHGEF3 mRNA CTD PMID:30951980 Arhgef3 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 Arhgef3 Rat 4,4'-sulfonyldiphenol decreases expression ISO Arhgef3 (Mus musculus) 6480464 bisphenol S results in decreased expression of ARHGEF3 mRNA CTD PMID:39298647 Arhgef3 Rat 4-hydroxynon-2-enal decreases expression ISO Arhgef3 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of ARHGEF3 mRNA CTD PMID:19191707 Arhgef3 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ARHGEF3 mRNA CTD PMID:24780913 Arhgef3 Rat aflatoxin B1 affects expression ISO ARHGEF3 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of ARHGEF3 protein CTD PMID:20106945 Arhgef3 Rat Aflatoxin B2 alpha increases methylation ISO ARHGEF3 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of ARHGEF3 intron CTD PMID:30157460 Arhgef3 Rat all-trans-retinoic acid increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Tretinoin results in increased expression of ARHGEF3 mRNA CTD PMID:21934132 and PMID:33167477 Arhgef3 Rat antirheumatic drug decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ARHGEF3 mRNA CTD PMID:24449571 Arhgef3 Rat benzo[a]pyrene increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ARHGEF3 mRNA CTD PMID:20106945 Arhgef3 Rat benzo[a]pyrene decreases methylation ISO ARHGEF3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of ARHGEF3 promoter CTD PMID:27901495 Arhgef3 Rat benzo[a]pyrene affects methylation ISO ARHGEF3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ARHGEF3 5' UTR and Benzo(a)pyrene affects the methylation of ARHGEF3 intron CTD PMID:27901495 and PMID:30157460 Arhgef3 Rat benzo[b]fluoranthene increases expression ISO Arhgef3 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of ARHGEF3 mRNA CTD PMID:26377693 Arhgef3 Rat benzo[e]pyrene increases methylation ISO ARHGEF3 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of ARHGEF3 intron CTD PMID:30157460 Arhgef3 Rat bis(2-chloroethyl) sulfide increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Mustard Gas results in increased expression of ARHGEF3 mRNA CTD PMID:25102026 Arhgef3 Rat bisphenol A decreases expression ISO Arhgef3 (Mus musculus) 6480464 bisphenol A results in decreased expression of ARHGEF3 mRNA CTD PMID:26063408 Arhgef3 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARHGEF3 mRNA CTD PMID:35192832 Arhgef3 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 Arhgef3 Rat bisphenol A increases methylation ISO ARHGEF3 (Homo sapiens) 6480464 bisphenol A results in increased methylation of ARHGEF3 gene CTD PMID:31601247 Arhgef3 Rat bisphenol A multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF3 gene CTD PMID:31601247 Arhgef3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARHGEF3 mRNA CTD PMID:32145629 Arhgef3 Rat bisphenol A increases expression ISO ARHGEF3 (Homo sapiens) 6480464 bisphenol A results in increased expression of ARHGEF3 mRNA CTD PMID:27685785 Arhgef3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARHGEF3 mRNA CTD PMID:25181051 Arhgef3 Rat bisphenol F increases expression ISO Arhgef3 (Mus musculus) 6480464 bisphenol F results in increased expression of ARHGEF3 mRNA CTD PMID:30951980 and PMID:38685157 Arhgef3 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 Arhgef3 Rat cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ARHGEF3 promoter CTD PMID:22457795 Arhgef3 Rat cadmium dichloride decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of ARHGEF3 mRNA CTD PMID:38568856 Arhgef3 Rat calcitriol decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Calcitriol results in decreased expression of ARHGEF3 mRNA CTD PMID:16002434 Arhgef3 Rat carbamazepine affects expression ISO ARHGEF3 (Homo sapiens) 6480464 Carbamazepine affects the expression of ARHGEF3 mRNA CTD PMID:24752500 Arhgef3 Rat carbon nanotube decreases expression ISO Arhgef3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Arhgef3 Rat chlordecone affects response to substance ISO ARHGEF3 (Homo sapiens) 6480464 ARHGEF3 gene SNP affects the susceptibility to Chlordecone CTD PMID:25622337 Arhgef3 Rat chlorpyrifos increases expression ISO Arhgef3 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ARHGEF3 mRNA CTD PMID:32715474 Arhgef3 Rat cisplatin multiple interactions ISO Arhgef3 (Mus musculus) 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ARHGEF3 mRNA CTD PMID:23625948 Arhgef3 Rat clofibrate multiple interactions ISO Arhgef3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA] CTD PMID:17585979 Arhgef3 Rat clofibrate increases expression ISO Arhgef3 (Mus musculus) 6480464 Clofibrate results in increased expression of ARHGEF3 mRNA CTD PMID:23811191 Arhgef3 Rat copper atom increases expression EXP 6480464 Copper results in increased expression of ARHGEF3 mRNA CTD PMID:30556269 Arhgef3 Rat copper(0) increases expression EXP 6480464 Copper results in increased expression of ARHGEF3 mRNA CTD PMID:30556269 Arhgef3 Rat copper(II) sulfate decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ARHGEF3 mRNA CTD PMID:19549813 Arhgef3 Rat crocidolite asbestos decreases expression ISO Arhgef3 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of ARHGEF3 mRNA CTD PMID:29279043 Arhgef3 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ARHGEF3 mRNA CTD PMID:26577399 Arhgef3 Rat cyclosporin A increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ARHGEF3 mRNA CTD PMID:20106945 Arhgef3 Rat cyclosporin A decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ARHGEF3 mRNA CTD PMID:25562108 and PMID:27989131 Arhgef3 Rat cytarabine decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Cytarabine results in decreased expression of ARHGEF3 mRNA CTD PMID:21198554 Arhgef3 Rat dibutyl phthalate increases expression ISO Arhgef3 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of ARHGEF3 mRNA CTD PMID:21266533 Arhgef3 Rat diclofenac affects expression ISO ARHGEF3 (Homo sapiens) 6480464 Diclofenac affects the expression of ARHGEF3 mRNA CTD PMID:24752500 Arhgef3 Rat diclofenac decreases expression ISO Arhgef3 (Mus musculus) 6480464 Diclofenac results in decreased expression of ARHGEF3 mRNA CTD PMID:35537566 Arhgef3 Rat dorsomorphin multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Arhgef3 Rat doxorubicin decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ARHGEF3 mRNA CTD PMID:29803840 Arhgef3 Rat entinostat multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 Arhgef3 Rat entinostat increases expression ISO ARHGEF3 (Homo sapiens) 6480464 entinostat results in increased expression of ARHGEF3 mRNA CTD PMID:26272509 Arhgef3 Rat ethanol affects splicing ISO Arhgef3 (Mus musculus) 6480464 Ethanol affects the splicing of ARHGEF3 mRNA CTD PMID:30319688 Arhgef3 Rat fenthion decreases expression ISO Arhgef3 (Mus musculus) 6480464 Fenthion results in decreased expression of ARHGEF3 mRNA CTD PMID:34813904 Arhgef3 Rat fluvastatin multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA CTD PMID:16996129 Arhgef3 Rat formaldehyde decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of ARHGEF3 mRNA CTD PMID:20655997 Arhgef3 Rat fulvestrant multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF3 gene CTD PMID:31601247 Arhgef3 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARHGEF3 mRNA CTD PMID:22061828 and PMID:33387578 Arhgef3 Rat lead(0) affects expression ISO ARHGEF3 (Homo sapiens) 6480464 Lead affects the expression of ARHGEF3 mRNA CTD PMID:28903495 Arhgef3 Rat lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of ARHGEF3 mRNA CTD PMID:35283115 Arhgef3 Rat lipopolysaccharide multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Arhgef3 Rat lipopolysaccharide decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of ARHGEF3 mRNA CTD PMID:35811015 Arhgef3 Rat methapyrilene increases methylation ISO ARHGEF3 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of ARHGEF3 intron CTD PMID:30157460 Arhgef3 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ARHGEF3 gene CTD PMID:35440735 Arhgef3 Rat methyl methanesulfonate decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of ARHGEF3 mRNA CTD PMID:23649840 Arhgef3 Rat methylmercury chloride increases expression ISO ARHGEF3 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ARHGEF3 mRNA CTD PMID:28001369 Arhgef3 Rat nickel atom decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Nickel results in decreased expression of ARHGEF3 mRNA CTD PMID:23195993 Arhgef3 Rat ozone multiple interactions ISO Arhgef3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGEF3 mRNA CTD PMID:34911549 Arhgef3 Rat ozone multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARHGEF3 mRNA CTD PMID:35430440 Arhgef3 Rat ozone decreases expression EXP 6480464 Ozone results in decreased expression of ARHGEF3 mRNA CTD PMID:35737395 Arhgef3 Rat paracetamol multiple interactions ISO Arhgef3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA] CTD PMID:17585979 Arhgef3 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ARHGEF3 mRNA CTD PMID:33387578 Arhgef3 Rat paracetamol increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ARHGEF3 mRNA CTD PMID:22230336 Arhgef3 Rat perfluorohexanesulfonic acid decreases expression ISO Arhgef3 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of ARHGEF3 mRNA CTD PMID:37995155 Arhgef3 Rat phenobarbital affects expression ISO Arhgef3 (Mus musculus) 6480464 Phenobarbital affects the expression of ARHGEF3 mRNA CTD PMID:23091169 Arhgef3 Rat phenylmercury acetate increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of ARHGEF3 mRNA CTD PMID:26272509 Arhgef3 Rat phenylmercury acetate multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 Arhgef3 Rat PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of ARHGEF3 mRNA CTD PMID:15215175 Arhgef3 Rat pirinixic acid increases expression ISO Arhgef3 (Mus musculus) 6480464 pirinixic acid results in increased expression of ARHGEF3 mRNA CTD PMID:18301758 and PMID:23811191 Arhgef3 Rat potassium chromate multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 Arhgef3 Rat potassium chromate decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 Arhgef3 Rat pregnenolone 16alpha-carbonitrile increases expression ISO Arhgef3 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of ARHGEF3 mRNA CTD PMID:28903501 Arhgef3 Rat progesterone increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Progesterone results in increased expression of ARHGEF3 mRNA CTD PMID:18070364 Arhgef3 Rat quercetin decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Quercetin results in decreased expression of ARHGEF3 mRNA CTD PMID:21632981 Arhgef3 Rat resveratrol multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ARHGEF3 mRNA CTD PMID:23557933 Arhgef3 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Arhgef3 Rat SB 431542 multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Arhgef3 Rat silicon dioxide decreases expression ISO Arhgef3 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of ARHGEF3 mRNA CTD PMID:19073995 Arhgef3 Rat silver atom decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Silver results in decreased expression of ARHGEF3 mRNA CTD PMID:26014281 Arhgef3 Rat silver(0) decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Silver results in decreased expression of ARHGEF3 mRNA CTD PMID:26014281 Arhgef3 Rat sodium arsenite affects methylation ISO ARHGEF3 (Homo sapiens) 6480464 sodium arsenite affects the methylation of ARHGEF3 gene CTD PMID:28589171 Arhgef3 Rat sodium arsenite increases expression ISO Arhgef3 (Mus musculus) 6480464 sodium arsenite results in increased expression of ARHGEF3 mRNA CTD PMID:36209798 Arhgef3 Rat sunitinib decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ARHGEF3 mRNA CTD PMID:31533062 Arhgef3 Rat testosterone multiple interactions ISO Arhgef3 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 Arhgef3 Rat testosterone increases expression ISO Arhgef3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of ARHGEF3 mRNA CTD PMID:33848595 Arhgef3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ARHGEF3 mRNA CTD PMID:31150632 Arhgef3 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARHGEF3 mRNA CTD PMID:23411599 and PMID:34492290 Arhgef3 Rat titanium dioxide decreases methylation ISO Arhgef3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ARHGEF3 gene CTD PMID:35295148 Arhgef3 Rat trichloroethene increases expression ISO Arhgef3 (Mus musculus) 6480464 Trichloroethylene results in increased expression of ARHGEF3 mRNA CTD PMID:25549359 Arhgef3 Rat trichostatin A increases expression ISO ARHGEF3 (Homo sapiens) 6480464 trichostatin A results in increased expression of ARHGEF3 mRNA CTD PMID:24935251 more ... Arhgef3 Rat trichostatin A multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 Arhgef3 Rat triclosan increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Triclosan results in increased expression of ARHGEF3 mRNA CTD PMID:30510588 Arhgef3 Rat triphenyl phosphate affects expression ISO ARHGEF3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of ARHGEF3 mRNA CTD PMID:37042841 Arhgef3 Rat trovafloxacin decreases expression ISO Arhgef3 (Mus musculus) 6480464 trovafloxacin results in decreased expression of ARHGEF3 mRNA CTD PMID:35537566 Arhgef3 Rat tungsten decreases expression ISO Arhgef3 (Mus musculus) 6480464 Tungsten results in decreased expression of ARHGEF3 mRNA CTD PMID:30912803 Arhgef3 Rat valproic acid increases expression ISO ARHGEF3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ARHGEF3 mRNA CTD PMID:23179753 more ... Arhgef3 Rat valproic acid multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 Arhgef3 Rat vorinostat multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 Arhgef3 Rat zinc sulfate decreases expression ISO ARHGEF3 (Homo sapiens) 6480464 Zinc Sulfate results in decreased expression of ARHGEF3 mRNA CTD PMID:12756304 Arhgef3 Rat zoledronic acid multiple interactions ISO ARHGEF3 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA CTD PMID:16996129
(-)-epigallocatechin 3-gallate (ISO) 17beta-estradiol (EXP) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-palmitoylglycerol (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxynon-2-enal (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) antirheumatic drug (ISO) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) benzo[e]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) cadmium dichloride (EXP,ISO) calcitriol (ISO) carbamazepine (ISO) carbon nanotube (ISO) chlordecone (ISO) chlorpyrifos (ISO) cisplatin (ISO) clofibrate (ISO) copper atom (EXP) copper(0) (EXP) copper(II) sulfate (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) cyclosporin A (ISO) cytarabine (ISO) dibutyl phthalate (ISO) diclofenac (ISO) dorsomorphin (ISO) doxorubicin (ISO) entinostat (ISO) ethanol (ISO) fenthion (ISO) fluvastatin (ISO) formaldehyde (ISO) fulvestrant (ISO) gentamycin (EXP) lead(0) (ISO) lidocaine (EXP) lipopolysaccharide (ISO) methapyrilene (ISO) methoxychlor (EXP) methyl methanesulfonate (ISO) methylmercury chloride (ISO) nickel atom (ISO) ozone (EXP,ISO) paracetamol (EXP,ISO) perfluorohexanesulfonic acid (ISO) phenobarbital (ISO) phenylmercury acetate (ISO) PhIP (EXP) pirinixic acid (ISO) potassium chromate (ISO) pregnenolone 16alpha-carbonitrile (ISO) progesterone (ISO) quercetin (ISO) resveratrol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sunitinib (ISO) testosterone (ISO) tetrachloromethane (EXP) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (ISO) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) trovafloxacin (ISO) tungsten (ISO) valproic acid (ISO) vorinostat (ISO) zinc sulfate (ISO) zoledronic acid (ISO)
Arhgef3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 2,308,311 - 2,588,634 (+) NCBI GRCr8 mRatBN7.2 16 2,301,573 - 2,581,951 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 2,300,138 - 2,581,945 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 16 2,519,162 - 2,588,620 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 3,664,854 - 3,734,303 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 2,523,968 - 2,593,442 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 2,743,714 - 3,026,768 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 2,743,823 - 3,026,760 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 16 2,595,636 - 2,665,051 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 16 2,473,664 - 2,663,130 (+) NCBI Celera 16 2,477,340 - 2,546,773 (+) NCBI Celera Cytogenetic Map 16 p16 NCBI
ARHGEF3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 56,727,420 - 57,079,268 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 56,727,418 - 57,079,329 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 56,761,448 - 57,113,296 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 56,736,486 - 56,810,993 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 56,736,485 - 56,810,993 NCBI Celera 3 56,727,164 - 57,078,931 (-) NCBI Celera Cytogenetic Map 3 p14.3 NCBI HuRef 3 56,809,905 - 57,161,427 (-) NCBI HuRef CHM1_1 3 56,712,114 - 57,063,671 (-) NCBI CHM1_1 T2T-CHM13v2.0 3 56,767,765 - 57,119,568 (-) NCBI T2T-CHM13v2.0
Arhgef3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 26,836,418 - 27,125,873 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 26,836,856 - 27,125,868 (+) Ensembl GRCm39 Ensembl GRCm38 14 27,114,461 - 27,403,916 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 27,114,899 - 27,403,911 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 14 28,051,225 - 28,217,090 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 14 26,064,923 - 26,230,788 (+) NCBI MGSCv36 mm8 Celera 14 23,496,924 - 23,635,464 (+) NCBI Celera Cytogenetic Map 14 A3 NCBI cM Map 14 16.09 NCBI
Arhgef3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955430 6,513,765 - 6,834,892 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955430 6,515,949 - 6,837,997 (-) NCBI ChiLan1.0 ChiLan1.0
ARHGEF3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 56,714,391 - 57,058,722 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 56,719,160 - 57,063,481 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 56,663,382 - 57,012,955 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 57,878,054 - 58,223,189 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 57,878,054 - 58,179,339 (-) Ensembl panpan1.1 panPan2
ARHGEF3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 20 33,318,255 - 33,625,364 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 20 33,311,630 - 33,623,704 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 20 33,245,620 - 33,552,246 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 20 33,590,514 - 33,894,766 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 20 33,590,505 - 33,895,184 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 20 33,039,576 - 33,340,539 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 20 33,398,192 - 33,701,068 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 20 33,569,536 - 33,873,906 (+) NCBI UU_Cfam_GSD_1.0
Arhgef3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 173,981,524 - 174,282,332 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936473 7,119,501 - 7,291,495 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936473 7,120,097 - 7,387,797 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ARHGEF3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 38,581,574 - 38,657,128 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 38,582,618 - 38,925,599 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 42,429,458 - 42,455,396 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ARHGEF3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 22 18,059,377 - 18,398,742 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 22 18,058,302 - 18,398,213 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 148,467,024 - 148,812,742 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Arhgef3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 434 Count of miRNA genes: 238 Interacting mature miRNAs: 288 Transcripts: ENSRNOT00000019511 Prediction methods: Microtar, Miranda, Targetscan Result types: miRGate_prediction
631561 Hcuc2 Hepatic copper content QTL 2 2.8 liver copper amount (VT:0003065) liver total copper weight (CMO:0001507) 16 1 39533949 Rat 1582235 Insul8 Insulin level QTL 8 3.3 0.0063 blood insulin amount (VT:0001560) calculated serum insulin level (CMO:0000359) 16 1 26727669 Rat 1549842 Bp248 Blood pressure QTL 248 0.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 380245 2995463 Rat 2307172 Activ4 Activity QTL 4 3.71 0.00023 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 16 1 33418960 Rat 1354584 Despr6 Despair related QTL 6 3.1 0.0067 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 1 39533930 Rat 1357403 Slep4 Serum leptin concentration QTL 4 3.91 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 1 9639137 Rat 2302380 Slep6 Serum leptin concentration QTL 6 3.36 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 1 32139025 Rat 12903952 Cm117 Cardiac mass QTL 117 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 16 832380 2995225 Rat 9590151 Scort8 Serum corticosterone level QTL 8 8.45 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 16 1 30836262 Rat 1354625 Despr7 Despair related QTL 7 3.16 0.016 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 1 44977551 Rat 12903954 Bw186 Body weight QTL 186 0.011 body mass (VT:0001259) body weight (CMO:0000012) 16 832380 2995225 Rat 12903955 Kidm69 Kidney mass QTL 69 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 16 832380 4227609 Rat 631830 Alc7 Alcohol consumption QTL 7 2.9 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 1 26727669 Rat 7411664 Foco30 Food consumption QTL 30 11 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 16 1 44588133 Rat 1600378 Arunc4 Aerobic running capacity QTL 4 0.03 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 16 380245 80345693 Rat 1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 16 1 22477621 Rat 12903278 Am16 Aortic mass QTL 16 0.019 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 16 832380 2995225 Rat 12903279 Cm115 Cardiac mass QTL 115 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 16 832380 2995225 Rat 2325838 Bp347 Blood pressure QTL 347 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 1 3080679 Rat 2303566 Bw90 Body weight QTL 90 2 body mass (VT:0001259) body weight (CMO:0000012) 16 1 39533930 Rat 2312663 Slep9 Serum leptin concentration QTL 9 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 832236 59492508 Rat 12903281 Cm116 Cardiac mass QTL 116 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 16 832380 2995225 Rat 2312660 Bw95 Body weight QTL 95 0.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 16 832236 59492508 Rat 2312666 Insul16 Insulin level QTL 16 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 16 832236 59492508 Rat 634355 Rends4 Renal damage susceptibility QTL 4 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 16 1 26727669 Rat 2293343 Glom16 Glomerulus QTL 16 7.4 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 16 832236 46053497 Rat 6903319 Bw114 Body weight QTL 114 2.7 0.0037 body mass (VT:0001259) body weight (CMO:0000012) 16 1 43534949 Rat 2312669 Stl23 Serum triglyceride level QTL 23 0.01 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 16 832236 59492508 Rat 2301404 Bp321 Blood pressure QTL 321 0.05 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 832380 2995225 Rat
D16Chm16
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 16 2,552,512 - 2,552,695 (+) MAPPER mRatBN7.2 Rnor_6.0 16 2,997,172 - 2,997,352 NCBI Rnor6.0 Rnor_5.0 16 2,964,567 - 2,964,747 UniSTS Rnor5.0 RGSC_v3.4 16 2,635,636 - 2,635,816 UniSTS RGSC3.4 Celera 16 2,517,339 - 2,517,519 UniSTS Cytogenetic Map 16 p16 UniSTS
D16Chm43
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 16 2,526,783 - 2,526,987 (+) MAPPER mRatBN7.2 Rnor_6.0 16 2,971,447 - 2,971,646 NCBI Rnor6.0 Rnor_5.0 16 2,938,842 - 2,939,041 UniSTS Rnor5.0 RGSC_v3.4 16 2,609,911 - 2,610,110 UniSTS RGSC3.4 Celera 16 2,491,614 - 2,491,813 UniSTS Cytogenetic Map 16 p16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000019511 ⟹ ENSRNOP00000019511
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,512,511 - 2,581,937 (+) Ensembl Rnor_6.0 Ensembl 16 2,958,283 - 3,026,760 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000087873 ⟹ ENSRNOP00000070700
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,301,668 - 2,581,939 (+) Ensembl Rnor_6.0 Ensembl 16 2,743,823 - 3,025,019 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000096646 ⟹ ENSRNOP00000086642
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,418,116 - 2,581,945 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000101017 ⟹ ENSRNOP00000095441
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,302,207 - 2,581,945 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000106161 ⟹ ENSRNOP00000085357
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,306,807 - 2,581,939 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000108807 ⟹ ENSRNOP00000092034
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,360,574 - 2,581,945 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000118865 ⟹ ENSRNOP00000086947
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,360,837 - 2,581,945 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000119297 ⟹ ENSRNOP00000097424
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,538,241 - 2,581,945 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000119548 ⟹ ENSRNOP00000097457
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 2,300,138 - 2,581,945 (+) Ensembl
RefSeq Acc Id:
NM_001106061 ⟹ NP_001099531
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,519,211 - 2,588,626 (+) NCBI mRatBN7.2 16 2,512,511 - 2,581,937 (+) NCBI Rnor_6.0 16 2,958,283 - 3,026,760 (+) NCBI Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI RGSC_v3.4 16 2,595,636 - 2,665,051 (+) RGD Celera 16 2,477,340 - 2,546,773 (+) RGD
Sequence:
CGTTGTAGGTGTTCGCGTCGCCGCCGCCGGCATCGTGGAGCTCGGGCCCTCTTTTACCCGGGATTTTTGTTGTCGCCTGGGATCAGCGGTGACATCGCAAAGGGCAGGCCCGGCAGCTGCCATGGTGG CCAAGGATTACCCCTTCTACCTCACTGTCAAGAGGGCAAACTGCAGCTTGGAGGCGCCCCTGGGCAGCGGGGTGGCCAAGGACGAGGAACCTAGTAACAAAAGGGTCAAACCCCTTTCCAGAGTCACA TCGCTAGCAAACCTCATCCCACCTGTGAAGACCACACCGTTAAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCGCAATGAGAGCCGCCCCGACATCCTCGCCCCTAGAGCCTGGTCCAG AAATGCCACCTCCTCAAGCACGAAGCGGAGGGACAGCAAACTCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCACAGCCAAGGAGATCAAGAGACAGGAGGCAATTTTTGAGCTTTCTC AAGGTGAAGAGGATTTGATAGAGGACTTGAAATTAGCAAAAAAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACAGAACAAGAGCTGAATCAGATTTTTGGAACACTGGACTCTCTAATC CCTCTCCATGAAGACCTCCTTAGTCAGCTTCGAGATGTTCGGAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGTGGGCTGGCTGCCTTGTCTCAGCTCCTATGACAGCTACTGCAGCAA TCAAGTTGCTGCCAAAGCCCTGCTGGACCACAAGAAGCAGGACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCACCCTTCAGCCGCAAACTCGACCTCTGGAATTTCCTTGATATTCCCC GGAGCCGGCTAGTGAAGTACCCTCTGCTCCTTCGAGAAATCCTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTGGAAGAAGCTATAAACATCATTCAGGGAATTGTGGCAGAAATCAAC ACCAAGACTGGGGAATCGGAATGCCGTTATTACAAAGAGCGGCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGACAGCTCAAGGGTCCTGTGTTGTCATGGAGAGCTGAAAAATAACCG GGGTGTGAAACTCCATGTTTTCCTGTTCCAAGAAGTGCTGGTGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATCAGTTGTACCGGCAGCCCATCCCTGTGAAGGACCTCACTCTGGAAG ACCTGCAGGATGGAGAAGTGCGGCTGGGTGGCTCCCTGCGTGGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGAGTCAGTTTCAAGAACGGATCCCAAAGTCAGACCCACTCACTGCAA GCCAACGACACCTTCAACAAACAACAGTGGCTCAACTGTATCCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGCTGGCTTGCTTGACTCCGAGAGCCTGTCCCAGAGTCCTGGCACTGA GAACAGGGAGCTGCGGGGAGAAACAAAACTTGAGCAGATGGACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCGAGGTCAGCCTCGAATGCGAGCGGATGGAACAGACAGACGCTTCCT GTGCAAACAGTAGGCCCGAGGAGAACGTCTGACAGAGGCTGTGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGTTTGTATTCCACACGGGAACAGTTTGGAGAGGCACTTTGTAATACT CCTGTGCCTGTGTTGGCCTAGCCCCTGTGTCTACTCCTTGTCCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAGCAGCCCTTACCCTGTTGCTGTATCCCACAAGCATCTGGATGAGTG CGGAGGAATGGACCATGTTACTTCGAGTTGTCCTACATTCAAAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGCCTTTGTCTCATGCTTGCCTAGTGTTCCTCTAGCTCTGACATAGTC GCTGAAGTCCTGGCACTGGGAGAGCTCTGCAGAATACTGAGATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGAGGGAACTCCAGTTTTGAGTTAATTCAACTAGAAAGCATGAAAAGC ATCTCTGGGGGTTTCTGAGGTTGGATTTTTGCAAAGGAGGAAGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGAATGTGAATAATCTGTGAAGACCTGAAACAGAGGTGGCTTTAGAAA GGGCCAAGACAAGAGCAGCTGCCGGACAGGCAAGCAGAGGCAGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAAATTCTAGTTCAAACTGAATTCCACCGTAAAAACAAAACAAAGCTA AAAGCACCAGCCAGCTCTGAATATTCAGCTGAAGTTGGGGGTGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTAGAAGAGCCCTTTCTAGCCTACAACATCAGGATTGCCAGGACCAGA GAAGATCTGCCAGGGTCATGTGACCCCATCAGCATTATGTTTCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGGGCTGGGGGATAGGGACACAGAGACTGTGACTGCATCCAGTGACTG TTGACAAACAAGAGAGAAGGACTTGGGGGTGAGAAATGTGTCACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAGTTACTCCGGAGGGTCTCAAGATTTCCTGCTCTGCTTTTGGGCCTG GTTCTAGAGCTACAGACGGACTGGTGGTTAATTCCCCTCGAGGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCAAACTGGAAAGTTCTTTGTTAAAGCCTTGCTTTACAGAGCAAGGAT GGGTAAAAAGACCTTGAGGGCGTGGTGGAAAAAACCGTTCACAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAGGATTTGTATAAAATTATACCCACACCAGCACTAGTAGTAATGATT CTAAATTATTGCCAAAAAGTTTTTTTTGTTTGTTGTTGTTAATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAATGCAAAGTTGTCCCTTTACTATGCACATGTGTCGTGCGCACTGAAA GAAGCCGTGTGGCAAGAGCAACCAATAGAAAAACAAGGTATATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTACCCTGTAAAGCCTATTTCTGTATTTATAGTTTTTAACCATGGTGA AAATTTTTTTCTATTATGAGTTTATTTAAAACCATTTTGTCTCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGACACAGTAGGAAGCTGAGACGGACCGGGCACTGGACGATAGAGAAA AGCCTGAAATGTTCTCTACAGAGCCATTGTGACCAGCGAGTTAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGTGAATGAATGTTCTGGTGAAATGAATACTTTTGTATAATGGCCTTA AACTTTTCTGGAAGCATTTCAAATAAATTGCAT
hide sequence
RefSeq Acc Id:
XM_006252574 ⟹ XP_006252636
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,308,700 - 2,588,634 (+) NCBI mRatBN7.2 16 2,301,979 - 2,581,951 (+) NCBI Rnor_6.0 16 2,744,176 - 3,026,768 (+) NCBI Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI
Sequence:
CAGGATCCTTACTCCGGAGACCGCGTCTTTTAAACTGCGCAGCGGACAGTCTTGAGATGGGAGG CGCCCGCCCAGAGCTGAAGGAAAGAAGAGCTGGACCTGGCAAGCTGAGTCTGCAGAGCATTTCACAGTGATGAATCAGTGCATTTACAGAGGGATGGAGGAGCACAAGGAAAGACCCAAGCGGCCAAG GCAGAACAACTTCTCCATGTTTCCCTCTCCCAAAGCCTGGAATTTCAGAGGGCGGAAACGGAAGCAGAGTGCCCAGGATGAAGATGCCGTCAGCCTATGCAGTCTTGACATAAGTGAACCTAGTAACA AAAGGGTCAAACCCCTTTCCAGAGTCACATCGCTAGCAAACCTCATCCCACCTGTGAAGACCACACCGTTAAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCGCAATGAGAGCCGCCCC GACATCCTCGCCCCTAGAGCCTGGTCCAGAAATGCCACCTCCTCAAGCACGAAGCGGAGGGACAGCAAACTCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCACAGCCAAGGAGATCAA GAGACAGGAGGCAATTTTTGAGCTTTCTCAAGGTGAAGAGGATTTGATAGAGGACTTGAAATTAGCAAAAAAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACAGAACAAGAGCTGAATC AGATTTTTGGAACACTGGACTCTCTAATCCCTCTCCATGAAGACCTCCTTAGTCAGCTTCGAGATGTTCGGAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGTGGGCTGGCTGCCTTGT CTCAGCTCCTATGACAGCTACTGCAGCAATCAAGTTGCTGCCAAAGCCCTGCTGGACCACAAGAAGCAGGACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCACCCTTCAGCCGCAAACT CGACCTCTGGAATTTCCTTGATATTCCCCGGAGCCGGCTAGTGAAGTACCCTCTGCTCCTTCGAGAAATCCTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTGGAAGAAGCTATAAACA TCATTCAGGGAATTGTGGCAGAAATCAACACCAAGACTGGGGAATCGGAATGCCGTTATTACAAAGAGCGGCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGACAGCTCAAGGGTCCTG TGTTGTCATGGAGAGCTGAAAAATAACCGGGGTGTGAAACTCCATGTTTTCCTGTTCCAAGAAGTGCTGGTGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATCAGTTGTACCGGCAGCC CATCCCTGTGAAGGACCTCACTCTGGAAGACCTGCAGGATGGAGAAGTGCGGCTGGGTGGCTCCCTGCGTGGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGAGTCAGTTTCAAGAACG GATCCCAAAGTCAGACCCACTCACTGCAAGCCAACGACACCTTCAACAAACAACAGTGGCTCAACTGTATCCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGCTGGCTTGCTTGACTCC GAGAGCCTGTCCCAGAGTCCTGGCACTGAGAACAGGGAGCTGCGGGGAGAAACAAAACTTGAGCAGATGGACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCGAGGTCAGCCTCGAATG CGAGCGGATGGAACAGACAGACGCTTCCTGTGCAAACAGTAGGCCCGAGGAGAACGTCTGACAGAGGCTGTGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGTTTGTATTCCACACGGG AACAGTTTGGAGAGGCACTTTGTAATACTCCTGTGCCTGTGTTGGCCTAGCCCCTGTGTCTACTCCTTGTCCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAGCAGCCCTTACCCTGTT GCTGTATCCCACAAGCATCTGGATGAGTGCGGAGGAATGGACCATGTTACTTCGAGTTGTCCTACATTCAAAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGCCTTTGTCTCATGCTTG CCTAGTGTTCCTCTAGCTCTGACATAGTCGCTGAAGTCCTGGCACTGGGAGAGCTCTGCAGAATACTGAGATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGAGGGAACTCCAGTTTTG AGTTAATTCAACTAGAAAGCATGAAAAGCATCTCTGGGGGTTTCTGAGGTTGGATTTTTGCAAAGGAGGAAGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGAATGTGAATAATCTGTG AAGACCTGAAACAGAGGTGGCTTTAGAAAGGGCCAAGACAAGAGCAGCTGCCGGACAGGCAAGCAGAGGCAGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAAATTCTAGTTCAAACTG AATTCCACCGTAAAAACAAAACAAAGCTAAAAGCACCAGCCAGCTCTGAATATTCAGCTGAAGTTGGGGGTGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTAGAAGAGCCCTTTCTAG CCTACAACATCAGGATTGCCAGGACCAGAGAAGATCTGCCAGGGTCATGTGACCCCATCAGCATTATGTTTCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGGGCTGGGGGATAGGGAC ACAGAGACTGTGACTGCATCCAGTGACTGTTGACAAACAAGAGAGAAGGACTTGGGGGTGAGAAATGTGTCACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAGTTACTCCGGAGGGTCT CAAGATTTCCTGCTCTGCTTTTGGGCCTGGTTCTAGAGCTACAGACGGACTGGTGGTTAATTCCCCTCGAGGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCAAACTGGAAAGTTCTTT GTTAAAGCCTTGCTTTACAGAGCAAGGATGGGTAAAAAGACCTTGAGGGCGTGGTGGAAAAAACCGTTCACAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAGGATTTGTATAAAATTA TACCCACACCAGCACTAGTAGTAATGATTCTAAATTATTGCCAAAAAGTTTTTTTTGTTTGTTGTTGTTAATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAATGCAAAGTTGTCCCTTT ACTATGCACATGTGTCGTGCGCACTGAAAGAAGCCGTGTGGCAAGAGCAACCAATAGAAAAACAAGGTATATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTACCCTGTAAAGCCTATT TCTGTATTTATAGTTTTTAACCATGGTGAAAATTTTTTTCTATTATGAGTTTATTTAAAACCATTTTGTCTCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGACACAGTAGGAAGCTGA GACGGACCGGGCACTGGACGATAGAGAAAAGCCTGAAATGTTCTCTACAGAGCCATTGTGACCAGCGAGTTAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGTGAATGAATGTTCTGGT GAAATGAATACTTTTGTATAATGGCCTTAAACTTTTCTGGAAGCATTTCAAATAAATTGCATTAAGAATA
hide sequence
RefSeq Acc Id:
XM_006252575 ⟹ XP_006252637
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,308,568 - 2,588,634 (+) NCBI mRatBN7.2 16 2,301,844 - 2,581,951 (+) NCBI Rnor_6.0 16 2,744,049 - 3,026,768 (+) NCBI Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI
Sequence:
GGAGAAAGTTCCTGGAGCCACTTCCGGGAGGGAGGCGCCACCTGTCTGGGGCGCGCCCTGACGCTGGACTTGTCCAGGAAAGAAGAGCTGGACCTGGCAAGCTGAGTCTGCAGAGCATTTCACAGTGA TGAATCAGTGCATTTACAGAGGGATGGAGGAGCACAAGGAAAGACCCAAGCGGCCAAGGCAGAACAACTTCTCCATGTTTCCCTCTCCCAAAGCCTGGAATTTCAGAGGGCGGAAACGGAAGCAGAGT GCCCAGGATGAAGATGCCGTCAGCCTATGCAGTCTTGACATAAGTGAACCTAGTAACAAAAGGGTCAAACCCCTTTCCAGAGTCACATCGCTAGCAAACCTCATCCCACCTGTGAAGACCACACCGTT AAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCGCAATGAGAGCCGCCCCGACATCCTCGCCCCTAGAGCCTGGTCCAGAAATGCCACCTCCTCAAGCACGAAGCGGAGGGACAGCAAAC TCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCACAGCCAAGGAGATCAAGAGACAGGAGGCAATTTTTGAGCTTTCTCAAGGTGAAGAGGATTTGATAGAGGACTTGAAATTAGCAAAA AAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACAGAACAAGAGCTGAATCAGATTTTTGGAACACTGGACTCTCTAATCCCTCTCCATGAAGACCTCCTTAGTCAGCTTCGAGATGTTCG GAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGTGGGCTGGCTGCCTTGTCTCAGCTCCTATGACAGCTACTGCAGCAATCAAGTTGCTGCCAAAGCCCTGCTGGACCACAAGAAGCAGG ACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCACCCTTCAGCCGCAAACTCGACCTCTGGAATTTCCTTGATATTCCCCGGAGCCGGCTAGTGAAGTACCCTCTGCTCCTTCGAGAAATC CTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTGGAAGAAGCTATAAACATCATTCAGGGAATTGTGGCAGAAATCAACACCAAGACTGGGGAATCGGAATGCCGTTATTACAAAGAGCG GCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGACAGCTCAAGGGTCCTGTGTTGTCATGGAGAGCTGAAAAATAACCGGGGTGTGAAACTCCATGTTTTCCTGTTCCAAGAAGTGCTGG TGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATCAGTTGTACCGGCAGCCCATCCCTGTGAAGGACCTCACTCTGGAAGACCTGCAGGATGGAGAAGTGCGGCTGGGTGGCTCCCTGCGT GGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGAGTCAGTTTCAAGAACGGATCCCAAAGTCAGACCCACTCACTGCAAGCCAACGACACCTTCAACAAACAACAGTGGCTCAACTGTAT CCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGCTGGCTTGCTTGACTCCGAGAGCCTGTCCCAGAGTCCTGGCACTGAGAACAGGGAGCTGCGGGGAGAAACAAAACTTGAGCAGATGG ACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCGAGGTCAGCCTCGAATGCGAGCGGATGGAACAGACAGACGCTTCCTGTGCAAACAGTAGGCCCGAGGAGAACGTCTGACAGAGGCTG TGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGTTTGTATTCCACACGGGAACAGTTTGGAGAGGCACTTTGTAATACTCCTGTGCCTGTGTTGGCCTAGCCCCTGTGTCTACTCCTTGT CCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAGCAGCCCTTACCCTGTTGCTGTATCCCACAAGCATCTGGATGAGTGCGGAGGAATGGACCATGTTACTTCGAGTTGTCCTACATTCA AAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGCCTTTGTCTCATGCTTGCCTAGTGTTCCTCTAGCTCTGACATAGTCGCTGAAGTCCTGGCACTGGGAGAGCTCTGCAGAATACTGAG ATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGAGGGAACTCCAGTTTTGAGTTAATTCAACTAGAAAGCATGAAAAGCATCTCTGGGGGTTTCTGAGGTTGGATTTTTGCAAAGGAGGA AGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGAATGTGAATAATCTGTGAAGACCTGAAACAGAGGTGGCTTTAGAAAGGGCCAAGACAAGAGCAGCTGCCGGACAGGCAAGCAGAGGC AGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAAATTCTAGTTCAAACTGAATTCCACCGTAAAAACAAAACAAAGCTAAAAGCACCAGCCAGCTCTGAATATTCAGCTGAAGTTGGGGG TGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTAGAAGAGCCCTTTCTAGCCTACAACATCAGGATTGCCAGGACCAGAGAAGATCTGCCAGGGTCATGTGACCCCATCAGCATTATGTT TCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGGGCTGGGGGATAGGGACACAGAGACTGTGACTGCATCCAGTGACTGTTGACAAACAAGAGAGAAGGACTTGGGGGTGAGAAATGTGT CACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAGTTACTCCGGAGGGTCTCAAGATTTCCTGCTCTGCTTTTGGGCCTGGTTCTAGAGCTACAGACGGACTGGTGGTTAATTCCCCTCGA GGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCAAACTGGAAAGTTCTTTGTTAAAGCCTTGCTTTACAGAGCAAGGATGGGTAAAAAGACCTTGAGGGCGTGGTGGAAAAAACCGTTCA CAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAGGATTTGTATAAAATTATACCCACACCAGCACTAGTAGTAATGATTCTAAATTATTGCCAAAAAGTTTTTTTTGTTTGTTGTTGTTA ATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAATGCAAAGTTGTCCCTTTACTATGCACATGTGTCGTGCGCACTGAAAGAAGCCGTGTGGCAAGAGCAACCAATAGAAAAACAAGGTAT ATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTACCCTGTAAAGCCTATTTCTGTATTTATAGTTTTTAACCATGGTGAAAATTTTTTTCTATTATGAGTTTATTTAAAACCATTTTGTC TCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGACACAGTAGGAAGCTGAGACGGACCGGGCACTGGACGATAGAGAAAAGCCTGAAATGTTCTCTACAGAGCCATTGTGACCAGCGAGT TAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGTGAATGAATGTTCTGGTGAAATGAATACTTTTGTATAATGGCCTTAAACTTTTCTGGAAGCATTTCAAATAAATTGCATTAAGAATA
hide sequence
RefSeq Acc Id:
XM_006252576 ⟹ XP_006252638
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,424,688 - 2,588,634 (+) NCBI mRatBN7.2 16 2,418,176 - 2,581,951 (+) NCBI Rnor_6.0 16 2,860,525 - 3,026,768 (+) NCBI Rnor_5.0 16 2,716,264 - 2,994,163 (+) NCBI
Sequence:
AGTAGCTATTTTTAAAAGGCACTAGAGAGAAGATGAGATGCCAGATTCGCTCAAGTGAAAAGAAAGCAGCGGATGGGTGTGTAGTTACTCTTAAATCATGGTTCTGTATGTGTCTGTGTCTTAGGAAG GACATGAAGTTCAAAGGACACCATTGATTTCTTTGTACCCAAAGGGGGCCTTCCTGCATCCCTCCTAGTGACGCTTCCTTGTCTCTCTATTTCACTCAAGTGTTTAAATATATAGAGCTCCACACAGG AGGCAGTGGAACAGTCCCAAGGGCTGCTGGGACATCTCACAAGTTTCTAGGTAGGGACCCAGTAAGCACAGCTTGCTTCTAAATGAGTCTCGGAGGTGGCTTTTGAATGCCAAAGCCAAGAGTGCTCG AAAGAGCGCCTGTAACCGGCAAGGAAACTACCAGGCGTAGGGAGCCCTGGGCTGGAGCTCTCAGCTTCTGACACTTGTAACGGATGGCCCCTGTCACTTCCTGTGCAACTTAAGTGGTGGGGAGGAGT TCCCTCAGGGAAACCATGCTCACACAGCTCAGAGCGCCCTGTCCACTAGGCTTTTCTGCGGTTAGCAGCCAGGGAGTTGGGGTGGATGAGGTCGGAGCGTCCCATGGTGTGGTGCTGTTTCTTTCTCC GTGCACAGCGGAAACGGAAGCAGAGTGCCCAGGATGAAGATGCCGTCAGCCTATGCAGTCTTGACATAAGTGAACCTAGTAACAAAAGGGTCAAACCCCTTTCCAGAGTCACATCGCTAGCAAACCTC ATCCCACCTGTGAAGACCACACCGTTAAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCGCAATGAGAGCCGCCCCGACATCCTCGCCCCTAGAGCCTGGTCCAGAAATGCCACCTCCTC AAGCACGAAGCGGAGGGACAGCAAACTCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCACAGCCAAGGAGATCAAGAGACAGGAGGCAATTTTTGAGCTTTCTCAAGGTGAAGAGGATT TGATAGAGGACTTGAAATTAGCAAAAAAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACAGAACAAGAGCTGAATCAGATTTTTGGAACACTGGACTCTCTAATCCCTCTCCATGAAGAC CTCCTTAGTCAGCTTCGAGATGTTCGGAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGTGGGCTGGCTGCCTTGTCTCAGCTCCTATGACAGCTACTGCAGCAATCAAGTTGCTGCCAA AGCCCTGCTGGACCACAAGAAGCAGGACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCACCCTTCAGCCGCAAACTCGACCTCTGGAATTTCCTTGATATTCCCCGGAGCCGGCTAGTGA AGTACCCTCTGCTCCTTCGAGAAATCCTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTGGAAGAAGCTATAAACATCATTCAGGGAATTGTGGCAGAAATCAACACCAAGACTGGGGAA TCGGAATGCCGTTATTACAAAGAGCGGCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGACAGCTCAAGGGTCCTGTGTTGTCATGGAGAGCTGAAAAATAACCGGGGTGTGAAACTCCA TGTTTTCCTGTTCCAAGAAGTGCTGGTGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATCAGTTGTACCGGCAGCCCATCCCTGTGAAGGACCTCACTCTGGAAGACCTGCAGGATGGAG AAGTGCGGCTGGGTGGCTCCCTGCGTGGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGAGTCAGTTTCAAGAACGGATCCCAAAGTCAGACCCACTCACTGCAAGCCAACGACACCTTC AACAAACAACAGTGGCTCAACTGTATCCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGCTGGCTTGCTTGACTCCGAGAGCCTGTCCCAGAGTCCTGGCACTGAGAACAGGGAGCTGCG GGGAGAAACAAAACTTGAGCAGATGGACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCGAGGTCAGCCTCGAATGCGAGCGGATGGAACAGACAGACGCTTCCTGTGCAAACAGTAGGC CCGAGGAGAACGTCTGACAGAGGCTGTGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGTTTGTATTCCACACGGGAACAGTTTGGAGAGGCACTTTGTAATACTCCTGTGCCTGTGTTG GCCTAGCCCCTGTGTCTACTCCTTGTCCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAGCAGCCCTTACCCTGTTGCTGTATCCCACAAGCATCTGGATGAGTGCGGAGGAATGGACCA TGTTACTTCGAGTTGTCCTACATTCAAAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGCCTTTGTCTCATGCTTGCCTAGTGTTCCTCTAGCTCTGACATAGTCGCTGAAGTCCTGGCA CTGGGAGAGCTCTGCAGAATACTGAGATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGAGGGAACTCCAGTTTTGAGTTAATTCAACTAGAAAGCATGAAAAGCATCTCTGGGGGTTTC TGAGGTTGGATTTTTGCAAAGGAGGAAGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGAATGTGAATAATCTGTGAAGACCTGAAACAGAGGTGGCTTTAGAAAGGGCCAAGACAAGAG CAGCTGCCGGACAGGCAAGCAGAGGCAGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAAATTCTAGTTCAAACTGAATTCCACCGTAAAAACAAAACAAAGCTAAAAGCACCAGCCAGC TCTGAATATTCAGCTGAAGTTGGGGGTGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTAGAAGAGCCCTTTCTAGCCTACAACATCAGGATTGCCAGGACCAGAGAAGATCTGCCAGGG TCATGTGACCCCATCAGCATTATGTTTCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGGGCTGGGGGATAGGGACACAGAGACTGTGACTGCATCCAGTGACTGTTGACAAACAAGAGA GAAGGACTTGGGGGTGAGAAATGTGTCACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAGTTACTCCGGAGGGTCTCAAGATTTCCTGCTCTGCTTTTGGGCCTGGTTCTAGAGCTACAG ACGGACTGGTGGTTAATTCCCCTCGAGGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCAAACTGGAAAGTTCTTTGTTAAAGCCTTGCTTTACAGAGCAAGGATGGGTAAAAAGACCTT GAGGGCGTGGTGGAAAAAACCGTTCACAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAGGATTTGTATAAAATTATACCCACACCAGCACTAGTAGTAATGATTCTAAATTATTGCCAA AAAGTTTTTTTTGTTTGTTGTTGTTAATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAATGCAAAGTTGTCCCTTTACTATGCACATGTGTCGTGCGCACTGAAAGAAGCCGTGTGGCAA GAGCAACCAATAGAAAAACAAGGTATATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTACCCTGTAAAGCCTATTTCTGTATTTATAGTTTTTAACCATGGTGAAAATTTTTTTCTATT ATGAGTTTATTTAAAACCATTTTGTCTCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGACACAGTAGGAAGCTGAGACGGACCGGGCACTGGACGATAGAGAAAAGCCTGAAATGTTCT CTACAGAGCCATTGTGACCAGCGAGTTAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGTGAATGAATGTTCTGGTGAAATGAATACTTTTGTATAATGGCCTTAAACTTTTCTGGAAGC ATTTCAAATAAATTGCATTAAGAATA
hide sequence
RefSeq Acc Id:
XM_017600022 ⟹ XP_017455511
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,544,634 - 2,588,634 (+) NCBI mRatBN7.2 16 2,538,106 - 2,581,951 (+) NCBI Rnor_6.0 16 2,980,878 - 3,026,768 (+) NCBI
Sequence:
CCCTTCCCTTTCCTCTGAATAGGAAAGAAAAGTAAAAGTCAATGGTAATTCATGAGAGAAATTC ACATCAAACGATATAAACAGAACTTTTTCTACATGATAAAGGGTCTCCCATGCTCTCATCAAGTACAATAAATATAAAATGGATGTTTAAAAAGAACTACTTCGTCAGATATGGGGGGTTGGAGATCA AGCTCAGCAGTTAGCAGCACTTGTCACCATTGCAGAGGTCCAGATTTGGTCCCAACATCCACACTGCCGCTCATAACCAGCTGTACCTCGGTTTCCAAGGGGTCTGACACCTTCTTCTGGTCTCCAAG GGTGCTAGGCACACACATGTATGATGCAGGCACATATTTATACACATTGCAAAGGGTCTACATAGGTAACCACTTCATTCATATATATTCAAATTTATTAATATGGATTTTTAAACACTTCGGGACCT GAGCCTGGTGACTCGGCCATACCAGCACTCGAGAATTAATGGCAAGAAGACCAGGCGTTCAAGACCAGCCTCCACCACATCAGTTTGCATTGGCCTGGATCGTACAGATACCCACAAAGCAACAGCGA CGTCAACAAAATCATTTTGGAGCCAACAGTTAGACTAGTGTCCCCGATATTTTAACTGGTAATAAACGCTCTACAGGTAGTCCTGTTAGAGGGACAAAACAACAAAGCCTAGAAAAGACTAACCAGAA CTATTGTGTTCAGACCTACTGCCCGCCTCTGCCCCTCCTTAAAGGGTCTTTAGGGATGTGCCCTCCTGCCTGCCGCAGGTCTCCTGGCAGTACTGGTACTGTGCACCCTGAAACAGTACATCGTGTGC CTGGGTGCAGCACTGACTGCCCAGCCTGGTCTAGCAGTATGCCGTGTTAGACCAGGCAGGCTCTGAAGGTTAAGTTCCGCCATCTTCCAGTAGCAAACCAGAACACAGCCTCAGTATTACACTTGCTA GTTAGTCAGTTCTCAGTAATACTATTTACTTAGAATCCTAGAAATATTTCCTCGAGGGCTCCTTAGACAGTAGTAAGATATAGCTGGAGACAGACTGAATAAATGGAAAAGAACAATTAAATTGGGCC AAGAAGTGTTTTAAATCTCTTATTCTCACAGAAGCCCTCAAAGGATAGCTCCATAATTCATACTTGATTCGTCTGGGTCAGACATAAGGCCTCCCTCCCCACTTAGATCCTACAACCGGAGAATATTC TGGAGCTTACACCTGCCTCGTTGCGAGCACTAAATCACAGCAGGGTGGCTTCTGGTTCATTCCTCTTTGCCTAGCAATGTTAGATCACCAGAGAGTAGCCTGCTGTTAACTCACTTGGGGGCCATACC TCGGAGAAGCAGTTCTAAATAGAATTCCATGTATTAGCAGTGTTCTGGACTAATGTTGCATTGACCATGTTTCCTATAACTATATTAGATAGTGCACATCTGAATAGACCATCTAAACGGAGCAGCCA CATCAGACCAACCTTAGAACACATGATCCATAAGGGCTAGATCTTCCTGCAGCCTGCCAAGTATGCCATGTTCCCTGCCCGATTTAAAGCAAGACACCCCTGCTGCTGCTCTCTCTTCAGCCTCCCCA TTCTGATACAGCTTTAACCGTGGGAATGAGACCCAACCTCTCTGGGATCTGAGGTGCACGCAGGATTATCCGAGACCAAGTCCTTTTCCCCTGGGATTTTTCCCGTGTGCCGCAGTGCGGTTTATGCT ACCCAAGAGAGCTGGATCTCAACCTGGCATTTCTAGACGAAAGCAGAAGCCATTTAGAGGATTCAGGGGACGCTTAAGAGGCTGTGTGTGCACACATGCGTGGACGCAGCCTGCTGAGGTTGCAGATC TGATGTAAAGAGGAGGAATCTTGACGTCATCCTCTGTGCACAGGTGCTCAGGAGCCCAGACCCTGGACAGGGGGCAGCATCCTGAGGACATCGTCGCCTGGAAGCAGGTGGCTTTCGGACTTTTCTCT GTAGCACTTTATCCTTCGTAGTGGCAGCCTTCATATCAGGAGACTCGTCTGCTGCATTTTAAAACCCAGCCTTCTTAGTGTTCCTAGCACTGCCTACTGGCTGCTCTGCGTAGCTCACTGAGAAGCCA GAGGTCCCTGGCTGCCGGATCTATTCTGTCTTAGAAAAAAGCAACCGACTGCTTCGCAAACCTCAGCTTACTCTTTGACACCATGGAACTGTTTTGAACTTCTTTAGGTTTAAATTTTTTTTTTCTAC TTAAAATGTCAGCAGTGTTGGTAGAGACTCAAGAGAGGGCTTCTGATTTCTGAGGCTGGACAGGGCACTGAGAGACATGAAAACTTCCCGGCTGAATTCCAGATTCATGAAGGAATTTTTCCGAGCAT CTGCTGCGTTTAGAATGGCCTGCAGGGATCCCTTGAAGAATTAGAAATTTTGGGTCAAACTTTGAGAGCAATGGCTGAGAAGGAAAGATGAACACCGTGGGGTAGGGGTCGGGTGAGCTGACCTTAGG AAATGATTGACATCTGCTACAACCGGCTGGCTTGGCTTTTCCCATCACAATTTGAGGTCTTCATGTGCTGTCCATTATCTACTGAAGATTAGATGGAGCGTAGGAAAGCAAGGGAACCTAGTAACAAA AGGGTCAAACCCCTTTCCAGAGTCACATCGCTAGCAAACCTCATCCCACCTGTGAAGACCACACCGTTAAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCGCAATGAGAGCCGCCCCGA CATCCTCGCCCCTAGAGCCTGGTCCAGAAATGCCACCTCCTCAAGCACGAAGCGGAGGGACAGCAAACTCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCACAGCCAAGGAGATCAAGA GACAGGAGGCAATTTTTGAGCTTTCTCAAGGTGAAGAGGATTTGATAGAGGACTTGAAATTAGCAAAAAAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACAGAACAAGAGCTGAATCAG ATTTTTGGAACACTGGACTCTCTAATCCCTCTCCATGAAGACCTCCTTAGTCAGCTTCGAGATGTTCGGAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGTGGGCTGGCTGCCTTGTCT CAGCTCCTATGACAGCTACTGCAGCAATCAAGTTGCTGCCAAAGCCCTGCTGGACCACAAGAAGCAGGACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCACCCTTCAGCCGCAAACTCG ACCTCTGGAATTTCCTTGATATTCCCCGGAGCCGGCTAGTGAAGTACCCTCTGCTCCTTCGAGAAATCCTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTGGAAGAAGCTATAAACATC ATTCAGGGAATTGTGGCAGAAATCAACACCAAGACTGGGGAATCGGAATGCCGTTATTACAAAGAGCGGCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGACAGCTCAAGGGTCCTGTG TTGTCATGGAGAGCTGAAAAATAACCGGGGTGTGAAACTCCATGTTTTCCTGTTCCAAGAAGTGCTGGTGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATCAGTTGTACCGGCAGCCCA TCCCTGTGAAGGACCTCACTCTGGAAGACCTGCAGGATGGAGAAGTGCGGCTGGGTGGCTCCCTGCGTGGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGAGTCAGTTTCAAGAACGGA TCCCAAAGTCAGACCCACTCACTGCAAGCCAACGACACCTTCAACAAACAACAGTGGCTCAACTGTATCCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGCTGGCTTGCTTGACTCCGA GAGCCTGTCCCAGAGTCCTGGCACTGAGAACAGGGAGCTGCGGGGAGAAACAAAACTTGAGCAGATGGACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCGAGGTCAGCCTCGAATGCG AGCGGATGGAACAGACAGACGCTTCCTGTGCAAACAGTAGGCCCGAGGAGAACGTCTGACAGAGGCTGTGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGTTTGTATTCCACACGGGAA CAGTTTGGAGAGGCACTTTGTAATACTCCTGTGCCTGTGTTGGCCTAGCCCCTGTGTCTACTCCTTGTCCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAGCAGCCCTTACCCTGTTGC TGTATCCCACAAGCATCTGGATGAGTGCGGAGGAATGGACCATGTTACTTCGAGTTGTCCTACATTCAAAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGCCTTTGTCTCATGCTTGCC TAGTGTTCCTCTAGCTCTGACATAGTCGCTGAAGTCCTGGCACTGGGAGAGCTCTGCAGAATACTGAGATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGAGGGAACTCCAGTTTTGAG TTAATTCAACTAGAAAGCATGAAAAGCATCTCTGGGGGTTTCTGAGGTTGGATTTTTGCAAAGGAGGAAGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGAATGTGAATAATCTGTGAA GACCTGAAACAGAGGTGGCTTTAGAAAGGGCCAAGACAAGAGCAGCTGCCGGACAGGCAAGCAGAGGCAGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAAATTCTAGTTCAAACTGAA TTCCACCGTAAAAACAAAACAAAGCTAAAAGCACCAGCCAGCTCTGAATATTCAGCTGAAGTTGGGGGTGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTAGAAGAGCCCTTTCTAGCC TACAACATCAGGATTGCCAGGACCAGAGAAGATCTGCCAGGGTCATGTGACCCCATCAGCATTATGTTTCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGGGCTGGGGGATAGGGACAC AGAGACTGTGACTGCATCCAGTGACTGTTGACAAACAAGAGAGAAGGACTTGGGGGTGAGAAATGTGTCACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAGTTACTCCGGAGGGTCTCA AGATTTCCTGCTCTGCTTTTGGGCCTGGTTCTAGAGCTACAGACGGACTGGTGGTTAATTCCCCTCGAGGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCAAACTGGAAAGTTCTTTGT TAAAGCCTTGCTTTACAGAGCAAGGATGGGTAAAAAGACCTTGAGGGCGTGGTGGAAAAAACCGTTCACAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAGGATTTGTATAAAATTATA CCCACACCAGCACTAGTAGTAATGATTCTAAATTATTGCCAAAAAGTTTTTTTTGTTTGTTGTTGTTAATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAATGCAAAGTTGTCCCTTTAC TATGCACATGTGTCGTGCGCACTGAAAGAAGCCGTGTGGCAAGAGCAACCAATAGAAAAACAAGGTATATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTACCCTGTAAAGCCTATTTC TGTATTTATAGTTTTTAACCATGGTGAAAATTTTTTTCTATTATGAGTTTATTTAAAACCATTTTGTCTCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGACACAGTAGGAAGCTGAGA CGGACCGGGCACTGGACGATAGAGAAAAGCCTGAAATGTTCTCTACAGAGCCATTGTGACCAGCGAGTTAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGTGAATGAATGTTCTGGTGA AATGAATACTTTTGTATAATGGCCTTAAACTTTTCTGGAAGCATTTCAAATAAATTGCATTAAGAATA
hide sequence
RefSeq Acc Id:
XM_017600023 ⟹ XP_017455512
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 2,308,311 - 2,588,634 (+) NCBI mRatBN7.2 16 2,301,573 - 2,581,951 (+) NCBI Rnor_6.0 16 2,743,714 - 3,026,768 (+) NCBI
Sequence:
GTCAGTCCTCCGCCAGCAGCCAGGCCCATCCTGAGGGGGGTCCCCGGGCCCGCCTCCCGCCCACGTGGCCCGCCCGGCCTCCAAGGCTCCGGCCCCGCCCCGCCCCGGGGAGTCGTCCCCGCAGTCAC CGCTGCGGCCCAGCAGGGCCGAGTCAGCGGGCGAGGAAAGAAGAGCTGGACCTGGCAAGCTGAGTCTGCAGAGCATTTCACAGTGATGAATCAGTGCATTTACAGAGGGATGGAGGAGCACAAGGAAA GACCCAAGCGGCCAAGGCAGAACAACTTCTCCATGTTTCCCTCTCCCAAAGCCTGGAATTTCAGAGGGCGGAAACGGAAGCAGAGTGCCCAGGATGAAGATGCCGTCAGCCTATGCAGTCTTGACATA AGTGAACCTAGTAACAAAAGGGTCAAACCCCTTTCCAGAGTCACATCGCTAGCAAACCTCATCCCACCTGTGAAGACCACACCGTTAAAGCGCTTCAGCCAAACCTTGCAGCGGTCCATCAGCTTCCG CAATGAGAGCCGCCCCGACATCCTCGCCCCTAGAGCCTGGTCCAGAAATGCCACCTCCTCAAGCACGAAGCGGAGGGACAGCAAACTCTGGAGTGAGACCTTCGATGTGTGTGTCAGTCAGGTGCTCA CAGCCAAGGAGATCAAGAGACAGGAGGCAATTTTTGAGCTTTCTCAAGGTGAAGAGGATTTGATAGAGGACTTGAAATTAGCAAAAAAGGCCTACCATGACCCCATGCTGAAACTCTCAATAATGACA GAACAAGAGCTGAATCAGATTTTTGGAACACTGGACTCTCTAATCCCTCTCCATGAAGACCTCCTTAGTCAGCTTCGAGATGTTCGGAAGCCCGATGGCTCGACGGAACACGTTGGTCCCATCCTCGT GGGCTGGCTGCCTTGTCTCAGCTCCTATGACAGCTACTGCAGCAATCAAGTTGCTGCCAAAGCCCTGCTGGACCACAAGAAGCAGGACCACAGAGTGCAGGATTTCCTCCAGCGCTGCTTAGAATCAC CCTTCAGCCGCAAACTCGACCTCTGGAATTTCCTTGATATTCCCCGGAGCCGGCTAGTGAAGTACCCTCTGCTCCTTCGAGAAATCCTGAGGCATACGCCAAACGATAATCCAGACCAGCAGCACCTG GAAGAAGCTATAAACATCATTCAGGGAATTGTGGCAGAAATCAACACCAAGACTGGGGAATCGGAATGCCGTTATTACAAAGAGCGGCTTCTTTACTTGGAAGAAGGCCAGAAAGATTCCCTGATTGA CAGCTCAAGGGTCCTGTGTTGTCATGGAGAGCTGAAAAATAACCGGGGTGTGAAACTCCATGTTTTCCTGTTCCAAGAAGTGCTGGTGATTACTCGAGCTGTCACGCACAATGAGCAACTCTGCTATC AGTTGTACCGGCAGCCCATCCCTGTGAAGGACCTCACTCTGGAAGACCTGCAGGATGGAGAAGTGCGGCTGGGTGGCTCCCTGCGTGGGGCCTTCAGCAACAATGAGAGAATTAAAAACTTCTTCAGA GTCAGTTTCAAGAACGGATCCCAAAGTCAGACCCACTCACTGCAAGCCAACGACACCTTCAACAAACAACAGTGGCTCAACTGTATCCGTCAGGCCAAAGAAACGGTTCTGTCTGCTGCCGGGCAGGC TGGCTTGCTTGACTCCGAGAGCCTGTCCCAGAGTCCTGGCACTGAGAACAGGGAGCTGCGGGGAGAAACAAAACTTGAGCAGATGGACCAATCGGACAGTGAGTCGGACTGCAGTATGGACACAAGCG AGGTCAGCCTCGAATGCGAGCGGATGGAACAGACAGACGCTTCCTGTGCAAACAGTAGGCCCGAGGAGAACGTCTGACAGAGGCTGTGACCCTGCCAGCAGCAGGCCCGTGTCTTACCTGTACAGTGT TTGTATTCCACACGGGAACAGTTTGGAGAGGCACTTTGTAATACTCCTGTGCCTGTGTTGGCCTAGCCCCTGTGTCTACTCCTTGTCCCTAGCACTGTAACTGCCACCCAGTCTGTGTCAGCTTGCAG CAGCCCTTACCCTGTTGCTGTATCCCACAAGCATCTGGATGAGTGCGGAGGAATGGACCATGTTACTTCGAGTTGTCCTACATTCAAAACAGAAAGACTCTCTAAACTACTGTTGTGCATGGCAAGGC CTTTGTCTCATGCTTGCCTAGTGTTCCTCTAGCTCTGACATAGTCGCTGAAGTCCTGGCACTGGGAGAGCTCTGCAGAATACTGAGATCGCATTGAAGGGAAGGCAGAAAGTCTGATTAACCCTTGGA GGGAACTCCAGTTTTGAGTTAATTCAACTAGAAAGCATGAAAAGCATCTCTGGGGGTTTCTGAGGTTGGATTTTTGCAAAGGAGGAAGCCTTGTTTTGAAGCCTGTGGTTTCATCCAGTGCAAGTTGA ATGTGAATAATCTGTGAAGACCTGAAACAGAGGTGGCTTTAGAAAGGGCCAAGACAAGAGCAGCTGCCGGACAGGCAAGCAGAGGCAGGAAGATGCGGAGTTCAAGAACAGCCTTGGCTACTTACCAA ATTCTAGTTCAAACTGAATTCCACCGTAAAAACAAAACAAAGCTAAAAGCACCAGCCAGCTCTGAATATTCAGCTGAAGTTGGGGGTGGATATTGGAGGCGTTTGTCATGGCCAATGGCTTGCCATTA GAAGAGCCCTTTCTAGCCTACAACATCAGGATTGCCAGGACCAGAGAAGATCTGCCAGGGTCATGTGACCCCATCAGCATTATGTTTCATCCTCCTCAGCCACTCCTCTTTTCCAGTGGTAATAGGGG GCTGGGGGATAGGGACACAGAGACTGTGACTGCATCCAGTGACTGTTGACAAACAAGAGAGAAGGACTTGGGGGTGAGAAATGTGTCACTGTCACCCAAGGCTCCTGCGTGAACCACAGAAATTGAAG TTACTCCGGAGGGTCTCAAGATTTCCTGCTCTGCTTTTGGGCCTGGTTCTAGAGCTACAGACGGACTGGTGGTTAATTCCCCTCGAGGCTGGTTTCATTAGCTCTTATTAACTAGAACCGGCTAGCCA AACTGGAAAGTTCTTTGTTAAAGCCTTGCTTTACAGAGCAAGGATGGGTAAAAAGACCTTGAGGGCGTGGTGGAAAAAACCGTTCACAAACTAGACAGAGCAGCTTCTGCAAGTGTAAATACTTAGAG GATTTGTATAAAATTATACCCACACCAGCACTAGTAGTAATGATTCTAAATTATTGCCAAAAAGTTTTTTTTGTTTGTTGTTGTTAATTTTTGCATCTATCAAAAGTTTACAGAAAAGAAAGCAAAAT GCAAAGTTGTCCCTTTACTATGCACATGTGTCGTGCGCACTGAAAGAAGCCGTGTGGCAAGAGCAACCAATAGAAAAACAAGGTATATGACATTATTATTTTTCAAGACCTATTTTGACCAGTTTCTA CCCTGTAAAGCCTATTTCTGTATTTATAGTTTTTAACCATGGTGAAAATTTTTTTCTATTATGAGTTTATTTAAAACCATTTTGTCTCTCAAGTTGCTGATGTAGCGAATAAACCTGCTCCGGGCAGA CACAGTAGGAAGCTGAGACGGACCGGGCACTGGACGATAGAGAAAAGCCTGAAATGTTCTCTACAGAGCCATTGTGACCAGCGAGTTAAGGAAGGGTCTCTGTCAGGGTCAGCCTGTGGGAAGAGAGT GAATGAATGTTCTGGTGAAATGAATACTTTTGTATAATGGCCTTAAACTTTTCTGGAAGCATTTCAAATAAATTGCATTAAGAATA
hide sequence
RefSeq Acc Id:
NP_001099531 ⟸ NM_001106061
- UniProtKB:
D4A1J1 (UniProtKB/TrEMBL), A6KMK9 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MVAKDYPFYLTVKRANCSLEAPLGSGVAKDEEPSNKRVKPLSRVTSLANLIPPVKTTPLKRFSQTLQRSISFRNESRPDILAPRAWSRNATSSSTKRRDSKLWSETFDVCVSQVLTAKEIKRQEAIFE LSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQIFGTLDSLIPLHEDLLSQLRDVRKPDGSTEHVGPILVGWLPCLSSYDSYCSNQVAAKALLDHKKQDHRVQDFLQRCLESPFSRKLDLWNFLD IPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINIIQGIVAEINTKTGESECRYYKERLLYLEEGQKDSLIDSSRVLCCHGELKNNRGVKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKDLT LEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAKETVLSAAGQAGLLDSESLSQSPGTENRELRGETKLEQMDQSDSESDCSMDTSEVSLECERMEQTD ASCANSRPEENV
hide sequence
RefSeq Acc Id:
XP_006252637 ⟸ XM_006252575
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2JYL3 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MNQCIYRGMEEHKERPKRPRQNNFSMFPSPKAWNFRGRKRKQSAQDEDAVSLCSLDISEPSNKR VKPLSRVTSLANLIPPVKTTPLKRFSQTLQRSISFRNESRPDILAPRAWSRNATSSSTKRRDSKLWSETFDVCVSQVLTAKEIKRQEAIFELSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQI FGTLDSLIPLHEDLLSQLRDVRKPDGSTEHVGPILVGWLPCLSSYDSYCSNQVAAKALLDHKKQDHRVQDFLQRCLESPFSRKLDLWNFLDIPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINII QGIVAEINTKTGESECRYYKERLLYLEEGQKDSLIDSSRVLCCHGELKNNRGVKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKDLTLEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGS QSQTHSLQANDTFNKQQWLNCIRQAKETVLSAAGQAGLLDSESLSQSPGTENRELRGETKLEQMDQSDSESDCSMDTSEVSLECERMEQTDASCANSRPEENV
hide sequence
RefSeq Acc Id:
XP_006252636 ⟸ XM_006252574
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2JYL3 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MNQCIYRGMEEHKERPKRPRQNNFSMFPSPKAWNFRGRKRKQSAQDEDAVSLCSLDISEPSNKRVKPLSRVTSLANLIPPVKTTPLKRFSQTLQRSISFRNESRPDILAPRAWSRNATSSSTKRRDSK LWSETFDVCVSQVLTAKEIKRQEAIFELSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQIFGTLDSLIPLHEDLLSQLRDVRKPDGSTEHVGPILVGWLPCLSSYDSYCSNQVAAKALLDHKKQ DHRVQDFLQRCLESPFSRKLDLWNFLDIPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINIIQGIVAEINTKTGESECRYYKERLLYLEEGQKDSLIDSSRVLCCHGELKNNRGVKLHVFLFQEVL VITRAVTHNEQLCYQLYRQPIPVKDLTLEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAKETVLSAAGQAGLLDSESLSQSPGTENRELRGETKLEQM DQSDSESDCSMDTSEVSLECERMEQTDASCANSRPEENV
hide sequence
RefSeq Acc Id:
XP_006252638 ⟸ XM_006252576
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6A424 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MRSERPMVWCCFFLRAQRKRKQSAQDEDAVSLCSLDISEPSNKRVKPLSRVTSLANLIPPVKTT PLKRFSQTLQRSISFRNESRPDILAPRAWSRNATSSSTKRRDSKLWSETFDVCVSQVLTAKEIKRQEAIFELSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQIFGTLDSLIPLHEDLLSQLRD VRKPDGSTEHVGPILVGWLPCLSSYDSYCSNQVAAKALLDHKKQDHRVQDFLQRCLESPFSRKLDLWNFLDIPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINIIQGIVAEINTKTGESECRYYK ERLLYLEEGQKDSLIDSSRVLCCHGELKNNRGVKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKDLTLEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLN CIRQAKETVLSAAGQAGLLDSESLSQSPGTENRELRGETKLEQMDQSDSESDCSMDTSEVSLECERMEQTDASCANSRPEENV
hide sequence
RefSeq Acc Id:
XP_017455512 ⟸ XM_017600023
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2JYL3 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MNQCIYRGMEEHKERPKRPRQNNFSMFPSPKAWNFRGRKRKQSAQDEDAVSLCSLDISEPSNKRVKPLSRVTSLANLIPPVKTTPLKRFSQTLQRSISFRNESRPDILAPRAWSRNATSSSTKRRDSK LWSETFDVCVSQVLTAKEIKRQEAIFELSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQIFGTLDSLIPLHEDLLSQLRDVRKPDGSTEHVGPILVGWLPCLSSYDSYCSNQVAAKALLDHKKQ DHRVQDFLQRCLESPFSRKLDLWNFLDIPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINIIQGIVAEINTKTGESECRYYKERLLYLEEGQKDSLIDSSRVLCCHGELKNNRGVKLHVFLFQEVL VITRAVTHNEQLCYQLYRQPIPVKDLTLEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAKETVLSAAGQAGLLDSESLSQSPGTENRELRGETKLEQM DQSDSESDCSMDTSEVSLECERMEQTDASCANSRPEENV
hide sequence
RefSeq Acc Id:
XP_017455511 ⟸ XM_017600022
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6GMI2 (UniProtKB/TrEMBL), A0A8I6GK05 (UniProtKB/TrEMBL)
- Sequence:
MERRKAREPSNKRVKPLSRVTSLANLIPPVKTTPLKRFSQTLQRSISFRNESRPDILAPRAWSR NATSSSTKRRDSKLWSETFDVCVSQVLTAKEIKRQEAIFELSQGEEDLIEDLKLAKKAYHDPMLKLSIMTEQELNQIFGTLDSLIPLHEDLLSQLRDVRKPDGSTEHVGPILVGWLPCLSSYDSYCSN QVAAKALLDHKKQDHRVQDFLQRCLESPFSRKLDLWNFLDIPRSRLVKYPLLLREILRHTPNDNPDQQHLEEAINIIQGIVAEINTKTGESECRYYKERLLYLEEGQKDSLIDSSRVLCCHGELKNNR GVKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKDLTLEDLQDGEVRLGGSLRGAFSNNERIKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAKETVLSAAGQAGLLDSESLSQSPGTE NRELRGETKLEQMDQSDSESDCSMDTSEVSLECERMEQTDASCANSRPEENV
hide sequence
Ensembl Acc Id:
ENSRNOP00000070700 ⟸ ENSRNOT00000087873
Ensembl Acc Id:
ENSRNOP00000019511 ⟸ ENSRNOT00000019511
Ensembl Acc Id:
ENSRNOP00000097424 ⟸ ENSRNOT00000119297
Ensembl Acc Id:
ENSRNOP00000092034 ⟸ ENSRNOT00000108807
Ensembl Acc Id:
ENSRNOP00000086947 ⟸ ENSRNOT00000118865
Ensembl Acc Id:
ENSRNOP00000085357 ⟸ ENSRNOT00000106161
Ensembl Acc Id:
ENSRNOP00000086642 ⟸ ENSRNOT00000096646
Ensembl Acc Id:
ENSRNOP00000095441 ⟸ ENSRNOT00000101017
Ensembl Acc Id:
ENSRNOP00000097457 ⟸ ENSRNOT00000119548
RGD ID: 13699901
Promoter ID: EPDNEW_R10422
Type: initiation region
Name: Arhgef3_2
Description: Rho guanine nucleotide exchange factor 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R10423
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 16 2,743,823 - 2,743,883 EPDNEW
RGD ID: 13699899
Promoter ID: EPDNEW_R10423
Type: multiple initiation site
Name: Arhgef3_1
Description: Rho guanine nucleotide exchange factor 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R10422
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 16 2,958,284 - 2,958,344 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-11-19
Arhgef3
Rho guanine nucleotide exchange factor 3
Arhgef3
Rho guanine nucleotide exchange factor (GEF) 3
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Arhgef3
Rho guanine nucleotide exchange factor (GEF) 3
Arhgef3_predicted
Rho guanine nucleotide exchange factor (GEF) 3 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Arhgef3_predicted
Rho guanine nucleotide exchange factor (GEF) 3 (predicted)
Symbol and Name status set to approved
70820
APPROVED